Aging and Disease is a bimonthly peer-reviewed journal of JKL International on behalf of the International Society on Aging and Disease, founded in 2010 and indexed in the Science Citation Index Expanded with a 2025 Impact Factor of 9.6Aging and Disease 是 JKL International 代表国际衰老与疾病学会出版的同行评审双月刊，创刊于 2010 年，被科学引文索引扩展版收录，2025 年影响因子为 9.6。
Basic, translational, and clinical research on the biology of ageing and age-related diseases发表衰老生物学与衰老相关疾病的基础、转化与临床研究。
Coverage of neurodegeneration, cardiovascular disease, cancer, diabetes, and immunity in ageing涵盖衰老过程中的神经退行性疾病、心血管疾病、癌症、糖尿病与免疫。
Studies on cellular senescence, stem cells, metabolism, and longevity mechanisms研究细胞衰老、干细胞、代谢与长寿机制。
Articles that connect fundamental ageing research to clinical interventions and therapeutics刊载将基础衰老研究与临床干预及治疗手段相联系的文章。
Reviews and perspectives on emerging topics in geroscience and age-related pathology发表老年科学与衰老相关病理新兴议题的综述与观点。
The journal was launched in 2010 by the International Society on Aging and Disease该刊于 2010 年由国际衰老与疾病学会创办。
It is published bimonthly and distributed by JKL International以双月刊形式出版，由 JKL International 发行。
Since its launch it has grown into a respected Q1 journal in geriatrics and gerontology自创刊以来，该刊已成长为老年医学与老年学领域备受认可的一区期刊。
It operates as a fully open access journal, making all content freely available online该刊采用完全开放获取模式，所有内容均可在线免费获取。
Editors-in-Chief include Kunlin Jin of the University of North Texas Health Science Center and David A. Greenberg of the Buck Institute for Research on Aging主编包括北得克萨斯大学健康科学中心的 Kunlin Jin 与巴克衰老研究所的 David A. Greenberg。
Associate editors oversee submissions across the breadth of ageing and disease research副主编负责衰老与疾病研究各方向的投稿处理。
The editorial board brings together international experts in geroscience and clinical ageing research编委会汇聚了老年科学与临床衰老研究领域的国际专家。
As a gold open access journal, all accepted articles are immediately freely available作为金色开放获取期刊，所有录用文章均立即免费开放。